Echo Therapeutics (PK) Stock Price - ECTE

0.01
-0.00035 (-3.38%)
0.01
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Echo Therapeutics (PK) ECTE OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.00035 -3.38% 0.01 0.01 0.01099 0.01 0.01035 16:27:15
Bid Price Ask Price Spread Spread % News
0.0078 0.011 0.0032 29.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 24,000 $ 0.01033 $ 248 9,202 0.0011 - 0.035
Last Trade Time Type Quantity Stock Price Currency
12:18:28 6,000 $ 0.01 USD

Echo Therapeutics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 132.97k 13.30M 10.88M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
52.80k $ - 0.00% - -

more financials information »

Echo Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ECTE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00780.010990.00780.00989626,9770.002228.21%
1 Month0.007960.011110.00660.00853066,4780.0020425.63%
3 Months0.00580.01350.00290.008615513,3150.004272.41%
6 Months0.0140.0140.00290.007530813,504-0.004-28.57%
1 Year0.00270.0350.00110.008730135,4240.0073270.37%
3 Years0.040.0550.00050.010369430,061-0.03-75.0%
5 Years1.451.450.00050.103061230,792-1.44-99.31%

Echo Therapeutics (PK) Description

We are a medical device company with expertise in advanced skin permeation technology. We are developing a non-invasive. wireless continuous glucose monitoring (CGM) system for initial use in the diabetes outpatient market. We believe other significant opportunities exist in the wearable-health consumer market and the hospital setting. The transdermal skin preparation component of our CGM System allows for enhanced skin permeation that will enable extraction of analytes such as glucose, enhanced delivery of topical pharmaceuticals and other applications.


Your Recent History
USOTC
ECTE
Echo Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.